Sestrin2 Is Increased in Calcific Aortic Disease and Inhibits Osteoblastic Differentiation in Valvular Interstitial Cells via the Nuclear Factor E2–related Factor 2 Pathway

Sestrin2 (Sesn2) is involved in the progression of cardiovascular diseases, such as hypertension and myocardial infarction. This study aimed to examine Sesn2 expression in human calcific aortic valve disease (CAVD) and explore its possible mechanisms by which Sesn2 participates in this process. CAVD...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Haixiong, Xi, Jicheng, Zhang, Zhibiao, Li, Jun, Guo, Liping, Li, Na, Sun, Yuehui, Li, Xiaofang, Han, Xuebin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of Cardiovascular Pharmacology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536529/
https://www.ncbi.nlm.nih.gov/pubmed/35881902
http://dx.doi.org/10.1097/FJC.0000000000001314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536529/
https://www.ncbi.nlm.nih.gov/pubmed/35881902
http://dx.doi.org/10.1097/FJC.0000000000001314

Ejemplares similares